Effect of evolocumab on the progression of intraplaque neovascularization of the carotid based on contrast-enhanced ultrasonography (EPIC study): A prospective single-arm, open-label study

Ju Chen, Faming Zhao, Chengbin Lei, Tianjun Qi, Xin Xue, Yuan Meng, Wenzhong Zhang, Hui Zhang, Jian Wang, Haijun Zhu, Cheng Cheng, Qilei Wang, Chenglong Bi, Beibei Song, Chengwei Jin, Qiang Niu, Fengshuang An, Bin Li, Xiaoguang Huo, Yunhe Zhao, Bo Li

Open source

DOI: 10.3389/fphar.2022.999224
Published: 2023-01-04
Container: Frontiers in Pharmacology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fphar.2022.999224,
  title = {Effect of evolocumab on the progression of intraplaque neovascularization of the carotid based on contrast-enhanced ultrasonography (EPIC study): A prospective single-arm, open-label study},
  author = {Ju Chen and Faming Zhao and Chengbin Lei and Tianjun Qi and Xin Xue and Yuan Meng and Wenzhong Zhang and Hui Zhang and Jian Wang and Haijun Zhu and Cheng Cheng and Qilei Wang and Chenglong Bi and Beibei Song and Chengwei Jin and Qiang Niu and Fengshuang An and Bin Li and Xiaoguang Huo and Yunhe Zhao and Bo Li},
  year = {2023},
  journal = {Frontiers in Pharmacology},
  doi = {10.3389/fphar.2022.999224},
  url = {https://doi.org/10.3389/fphar.2022.999224}
}

RIS

TY  - JOUR
TI  - Effect of evolocumab on the progression of intraplaque neovascularization of the carotid based on contrast-enhanced ultrasonography (EPIC study): A prospective single-arm, open-label study
AU  - Ju Chen
AU  - Faming Zhao
AU  - Chengbin Lei
AU  - Tianjun Qi
AU  - Xin Xue
AU  - Yuan Meng
AU  - Wenzhong Zhang
AU  - Hui Zhang
AU  - Jian Wang
AU  - Haijun Zhu
AU  - Cheng Cheng
AU  - Qilei Wang
AU  - Chenglong Bi
AU  - Beibei Song
AU  - Chengwei Jin
AU  - Qiang Niu
AU  - Fengshuang An
AU  - Bin Li
AU  - Xiaoguang Huo
AU  - Yunhe Zhao
AU  - Bo Li
PY  - 2023
JO  - Frontiers in Pharmacology
DO  - 10.3389/fphar.2022.999224
UR  - https://doi.org/10.3389/fphar.2022.999224
ER  -

APA

Chen, J., Zhao, F., Lei, C., Qi, T., Xue, X., Meng, Y., Zhang, W., Zhang, H., Wang, J., Zhu, H., Cheng, C., Wang, Q., Bi, C., Song, B., Jin, C., Niu, Q., An, F., Li, B., Huo, X., Zhao, Y., & Li, B. (2023). Effect of evolocumab on the progression of intraplaque neovascularization of the carotid based on contrast-enhanced ultrasonography (EPIC study): A prospective single-arm, open-label study. Frontiers in Pharmacology. https://doi.org/10.3389/fphar.2022.999224

Source records

crossref · retrieved 2026-11-06T07:16:06.674Z